57
OncoNano Medicine, Inc. raises $12.7M under Reg D
Company raise · Closed · Offering $12.7M · Sold $12.7M · DALLAS, TX · filed 2025-06-02
Placement agent engaged
52
OncoNano Medicine raises $15M in Dallas biotech offering
Company raise · Raising · DALLAS, TX · Form D filed 2026-10-08
OncoNano Medicine, a Delaware biotech corporation based in Dallas, is raising $15M under Regulation D exemption 06b. The company has sold $10.05M to 14 investors so far and retains $4.95M in remaining capacity.
$10M+ raisePlacement agent engagedother
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Brent Sorrells | Executive Officer |
| Brett Giroir | Executive Officer, Director |
| John Dyett | Director |
| Gina Jones | Director |
| Yumin Qui | Director |
Signed by Brett P. Giroir, Interim CEO/Chairman.
Placement agents / sales compensation: Salem Partners LLC
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.